Trial Profile
Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomised and cross-over study in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Apr 2013
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary)
- Indications Acute exacerbations of chronic bronchitis; Acute sinusitis; Bacterial infections; Community-acquired pneumonia; Intra-abdominal infections; Pelvic inflammatory disorders; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis
- Focus Pharmacokinetics
- 30 Apr 2013 New trial record